Interestingly, in pulmonary fibrosis, the negative regulation by macrophage efferocytosis is defective, and MerTK mainly exhibits profibrotic effects, suggesting that targeting MerTK in macrophages may help to attenuate pulmonary fibrosis [32]. The gene discussed is MERTK; the disease is pulmonary fibrosis.